Click for best price
Cancer Cell Biopsy Service Market Size, Share 2023
This report aims to provide a comprehensive presentation of the global market for Cancer Cell Biopsy Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cancer Cell Biopsy Service. This report contains market size and forecasts of Cancer Cell Biopsy Service in global, including the following market information:
Global Cancer Cell Biopsy Service Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Cancer Cell Biopsy Service market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Incisional Biopsy Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Cancer Cell Biopsy Service include ANGLE, Fluxion Biosciences, Inivata, GRAIL, Guardant Health, Caris, Liquid Biopsy Labs, DermTech and QIAGEN, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Cancer Cell Biopsy Service companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cancer Cell Biopsy Service Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Cancer Cell Biopsy Service Market Segment Percentages, by Type, 2022 (%)
Incisional Biopsy
Needle Biopsy
Global Cancer Cell Biopsy Service Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Cancer Cell Biopsy Service Market Segment Percentages, by Application, 2022 (%)
Hospital
Clinic
Global Cancer Cell Biopsy Service Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Cancer Cell Biopsy Service Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cancer Cell Biopsy Service revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Cancer Cell Biopsy Service revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
ANGLE
Fluxion Biosciences
Inivata
GRAIL
Guardant Health
Caris
Liquid Biopsy Labs
DermTech
QIAGEN
Lucence
Biocept
CELLSEARCH
Outline of Major Chapters:
Chapter 1: Introduces the definition of Cancer Cell Biopsy Service, market overview.
Chapter 2: Global Cancer Cell Biopsy Service market size in revenue.
Chapter 3: Detailed analysis of Cancer Cell Biopsy Service company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Cancer Cell Biopsy Service in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Cancer Cell Biopsy Service Market, Global Outlook and Forecast 2023-2029 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
68 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Cancer Cell Biopsy Service Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Cancer Cell Biopsy Service Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Cancer Cell Biopsy Service Overall Market Size
2.1 Global Cancer Cell Biopsy Service Market Size: 2022 VS 2029
2.2 Global Cancer Cell Biopsy Service Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Cancer Cell Biopsy Service Players in Global Market
3.2 Top Global Cancer Cell Biopsy Service Companies Ranked by Revenue
3.3 Global Cancer Cell Biopsy Service Revenue by Companies
3.4 Top 3 and Top 5 Cancer Cell Biopsy Service Companies in Global Market, by Revenue in 2022
3.5 Global Companies Cancer Cell Biopsy Service Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cancer Cell Biopsy Service Players in Global Market
3.6.1 List of Global Tier 1 Cancer Cell Biopsy Service Companies
3.6.2 List of Global Tier 2 and Tier 3 Cancer Cell Biopsy Service Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Cancer Cell Biopsy Service Market Size Markets, 2022 & 2029
4.1.2 Incisional Biopsy
4.1.3 Needle Biopsy
4.2 By Type - Global Cancer Cell Biopsy Service Revenue & Forecasts
4.2.1 By Type - Global Cancer Cell Biopsy Service Revenue, 2018-2023
4.2.2 By Type - Global Cancer Cell Biopsy Service Revenue, 2024-2029
4.2.3 By Type - Global Cancer Cell Biopsy Service Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Cancer Cell Biopsy Service Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Clinic
5.2 By Application - Global Cancer Cell Biopsy Service Revenue & Forecasts
5.2.1 By Application - Global Cancer Cell Biopsy Service Revenue, 2018-2023
5.2.2 By Application - Global Cancer Cell Biopsy Service Revenue, 2024-2029
5.2.3 By Application - Global Cancer Cell Biopsy Service Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Cancer Cell Biopsy Service Market Size, 2022 & 2029
6.2 By Region - Global Cancer Cell Biopsy Service Revenue & Forecasts
6.2.1 By Region - Global Cancer Cell Biopsy Service Revenue, 2018-2023
6.2.2 By Region - Global Cancer Cell Biopsy Service Revenue, 2024-2029
6.2.3 By Region - Global Cancer Cell Biopsy Service Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Cancer Cell Biopsy Service Revenue, 2018-2029
6.3.2 US Cancer Cell Biopsy Service Market Size, 2018-2029
6.3.3 Canada Cancer Cell Biopsy Service Market Size, 2018-2029
6.3.4 Mexico Cancer Cell Biopsy Service Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Cancer Cell Biopsy Service Revenue, 2018-2029
6.4.2 Germany Cancer Cell Biopsy Service Market Size, 2018-2029
6.4.3 France Cancer Cell Biopsy Service Market Size, 2018-2029
6.4.4 U.K. Cancer Cell Biopsy Service Market Size, 2018-2029
6.4.5 Italy Cancer Cell Biopsy Service Market Size, 2018-2029
6.4.6 Russia Cancer Cell Biopsy Service Market Size, 2018-2029
6.4.7 Nordic Countries Cancer Cell Biopsy Service Market Size, 2018-2029
6.4.8 Benelux Cancer Cell Biopsy Service Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Cancer Cell Biopsy Service Revenue, 2018-2029
6.5.2 China Cancer Cell Biopsy Service Market Size, 2018-2029
6.5.3 Japan Cancer Cell Biopsy Service Market Size, 2018-2029
6.5.4 South Korea Cancer Cell Biopsy Service Market Size, 2018-2029
6.5.5 Southeast Asia Cancer Cell Biopsy Service Market Size, 2018-2029
6.5.6 India Cancer Cell Biopsy Service Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Cancer Cell Biopsy Service Revenue, 2018-2029
6.6.2 Brazil Cancer Cell Biopsy Service Market Size, 2018-2029
6.6.3 Argentina Cancer Cell Biopsy Service Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Cancer Cell Biopsy Service Revenue, 2018-2029
6.7.2 Turkey Cancer Cell Biopsy Service Market Size, 2018-2029
6.7.3 Israel Cancer Cell Biopsy Service Market Size, 2018-2029
6.7.4 Saudi Arabia Cancer Cell Biopsy Service Market Size, 2018-2029
6.7.5 UAE Cancer Cell Biopsy Service Market Size, 2018-2029
7 Cancer Cell Biopsy Service Companies Profiles
7.1 ANGLE
7.1.1 ANGLE Company Summary
7.1.2 ANGLE Business Overview
7.1.3 ANGLE Cancer Cell Biopsy Service Major Product Offerings
7.1.4 ANGLE Cancer Cell Biopsy Service Revenue in Global Market (2018-2023)
7.1.5 ANGLE Key News & Latest Developments
7.2 Fluxion Biosciences
7.2.1 Fluxion Biosciences Company Summary
7.2.2 Fluxion Biosciences Business Overview
7.2.3 Fluxion Biosciences Cancer Cell Biopsy Service Major Product Offerings
7.2.4 Fluxion Biosciences Cancer Cell Biopsy Service Revenue in Global Market (2018-2023)
7.2.5 Fluxion Biosciences Key News & Latest Developments
7.3 Inivata
7.3.1 Inivata Company Summary
7.3.2 Inivata Business Overview
7.3.3 Inivata Cancer Cell Biopsy Service Major Product Offerings
7.3.4 Inivata Cancer Cell Biopsy Service Revenue in Global Market (2018-2023)
7.3.5 Inivata Key News & Latest Developments
7.4 GRAIL
7.4.1 GRAIL Company Summary
7.4.2 GRAIL Business Overview
7.4.3 GRAIL Cancer Cell Biopsy Service Major Product Offerings
7.4.4 GRAIL Cancer Cell Biopsy Service Revenue in Global Market (2018-2023)
7.4.5 GRAIL Key News & Latest Developments
7.5 Guardant Health
7.5.1 Guardant Health Company Summary
7.5.2 Guardant Health Business Overview
7.5.3 Guardant Health Cancer Cell Biopsy Service Major Product Offerings
7.5.4 Guardant Health Cancer Cell Biopsy Service Revenue in Global Market (2018-2023)
7.5.5 Guardant Health Key News & Latest Developments
7.6 Caris
7.6.1 Caris Company Summary
7.6.2 Caris Business Overview
7.6.3 Caris Cancer Cell Biopsy Service Major Product Offerings
7.6.4 Caris Cancer Cell Biopsy Service Revenue in Global Market (2018-2023)
7.6.5 Caris Key News & Latest Developments
7.7 Liquid Biopsy Labs
7.7.1 Liquid Biopsy Labs Company Summary
7.7.2 Liquid Biopsy Labs Business Overview
7.7.3 Liquid Biopsy Labs Cancer Cell Biopsy Service Major Product Offerings
7.7.4 Liquid Biopsy Labs Cancer Cell Biopsy Service Revenue in Global Market (2018-2023)
7.7.5 Liquid Biopsy Labs Key News & Latest Developments
7.8 DermTech
7.8.1 DermTech Company Summary
7.8.2 DermTech Business Overview
7.8.3 DermTech Cancer Cell Biopsy Service Major Product Offerings
7.8.4 DermTech Cancer Cell Biopsy Service Revenue in Global Market (2018-2023)
7.8.5 DermTech Key News & Latest Developments
7.9 QIAGEN
7.9.1 QIAGEN Company Summary
7.9.2 QIAGEN Business Overview
7.9.3 QIAGEN Cancer Cell Biopsy Service Major Product Offerings
7.9.4 QIAGEN Cancer Cell Biopsy Service Revenue in Global Market (2018-2023)
7.9.5 QIAGEN Key News & Latest Developments
7.10 Lucence
7.10.1 Lucence Company Summary
7.10.2 Lucence Business Overview
7.10.3 Lucence Cancer Cell Biopsy Service Major Product Offerings
7.10.4 Lucence Cancer Cell Biopsy Service Revenue in Global Market (2018-2023)
7.10.5 Lucence Key News & Latest Developments
7.11 Biocept
7.11.1 Biocept Company Summary
7.11.2 Biocept Business Overview
7.11.3 Biocept Cancer Cell Biopsy Service Major Product Offerings
7.11.4 Biocept Cancer Cell Biopsy Service Revenue in Global Market (2018-2023)
7.11.5 Biocept Key News & Latest Developments
7.12 CELLSEARCH
7.12.1 CELLSEARCH Company Summary
7.12.2 CELLSEARCH Business Overview
7.12.3 CELLSEARCH Cancer Cell Biopsy Service Major Product Offerings
7.12.4 CELLSEARCH Cancer Cell Biopsy Service Revenue in Global Market (2018-2023)
7.12.5 CELLSEARCH Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Cancer Cell Biopsy Service Market Opportunities & Trends in Global Market
Table 2. Cancer Cell Biopsy Service Market Drivers in Global Market
Table 3. Cancer Cell Biopsy Service Market Restraints in Global Market
Table 4. Key Players of Cancer Cell Biopsy Service in Global Market
Table 5. Top Cancer Cell Biopsy Service Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Cancer Cell Biopsy Service Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Cancer Cell Biopsy Service Revenue Share by Companies, 2018-2023
Table 8. Global Companies Cancer Cell Biopsy Service Product Type
Table 9. List of Global Tier 1 Cancer Cell Biopsy Service Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Cancer Cell Biopsy Service Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Cancer Cell Biopsy Service Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Cancer Cell Biopsy Service Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Cancer Cell Biopsy Service Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Cancer Cell Biopsy Service Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Cancer Cell Biopsy Service Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Cancer Cell Biopsy Service Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Cancer Cell Biopsy Service Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Cancer Cell Biopsy Service Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Cancer Cell Biopsy Service Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Cancer Cell Biopsy Service Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Cancer Cell Biopsy Service Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Cancer Cell Biopsy Service Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Cancer Cell Biopsy Service Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Cancer Cell Biopsy Service Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Cancer Cell Biopsy Service Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Cancer Cell Biopsy Service Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Cancer Cell Biopsy Service Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Cancer Cell Biopsy Service Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Cancer Cell Biopsy Service Revenue, (US$, Mn), 2024-2029
Table 30. ANGLE Company Summary
Table 31. ANGLE Cancer Cell Biopsy Service Product Offerings
Table 32. ANGLE Cancer Cell Biopsy Service Revenue (US$, Mn) & (2018-2023)
Table 33. ANGLE Key News & Latest Developments
Table 34. Fluxion Biosciences Company Summary
Table 35. Fluxion Biosciences Cancer Cell Biopsy Service Product Offerings
Table 36. Fluxion Biosciences Cancer Cell Biopsy Service Revenue (US$, Mn) & (2018-2023)
Table 37. Fluxion Biosciences Key News & Latest Developments
Table 38. Inivata Company Summary
Table 39. Inivata Cancer Cell Biopsy Service Product Offerings
Table 40. Inivata Cancer Cell Biopsy Service Revenue (US$, Mn) & (2018-2023)
Table 41. Inivata Key News & Latest Developments
Table 42. GRAIL Company Summary
Table 43. GRAIL Cancer Cell Biopsy Service Product Offerings
Table 44. GRAIL Cancer Cell Biopsy Service Revenue (US$, Mn) & (2018-2023)
Table 45. GRAIL Key News & Latest Developments
Table 46. Guardant Health Company Summary
Table 47. Guardant Health Cancer Cell Biopsy Service Product Offerings
Table 48. Guardant Health Cancer Cell Biopsy Service Revenue (US$, Mn) & (2018-2023)
Table 49. Guardant Health Key News & Latest Developments
Table 50. Caris Company Summary
Table 51. Caris Cancer Cell Biopsy Service Product Offerings
Table 52. Caris Cancer Cell Biopsy Service Revenue (US$, Mn) & (2018-2023)
Table 53. Caris Key News & Latest Developments
Table 54. Liquid Biopsy Labs Company Summary
Table 55. Liquid Biopsy Labs Cancer Cell Biopsy Service Product Offerings
Table 56. Liquid Biopsy Labs Cancer Cell Biopsy Service Revenue (US$, Mn) & (2018-2023)
Table 57. Liquid Biopsy Labs Key News & Latest Developments
Table 58. DermTech Company Summary
Table 59. DermTech Cancer Cell Biopsy Service Product Offerings
Table 60. DermTech Cancer Cell Biopsy Service Revenue (US$, Mn) & (2018-2023)
Table 61. DermTech Key News & Latest Developments
Table 62. QIAGEN Company Summary
Table 63. QIAGEN Cancer Cell Biopsy Service Product Offerings
Table 64. QIAGEN Cancer Cell Biopsy Service Revenue (US$, Mn) & (2018-2023)
Table 65. QIAGEN Key News & Latest Developments
Table 66. Lucence Company Summary
Table 67. Lucence Cancer Cell Biopsy Service Product Offerings
Table 68. Lucence Cancer Cell Biopsy Service Revenue (US$, Mn) & (2018-2023)
Table 69. Lucence Key News & Latest Developments
Table 70. Biocept Company Summary
Table 71. Biocept Cancer Cell Biopsy Service Product Offerings
Table 72. Biocept Cancer Cell Biopsy Service Revenue (US$, Mn) & (2018-2023)
Table 73. Biocept Key News & Latest Developments
Table 74. CELLSEARCH Company Summary
Table 75. CELLSEARCH Cancer Cell Biopsy Service Product Offerings
Table 76. CELLSEARCH Cancer Cell Biopsy Service Revenue (US$, Mn) & (2018-2023)
Table 77. CELLSEARCH Key News & Latest Developments
List of Figures
Figure 1. Cancer Cell Biopsy Service Segment by Type in 2022
Figure 2. Cancer Cell Biopsy Service Segment by Application in 2022
Figure 3. Global Cancer Cell Biopsy Service Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Cancer Cell Biopsy Service Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Cancer Cell Biopsy Service Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Cancer Cell Biopsy Service Revenue in 2022
Figure 8. By Type - Global Cancer Cell Biopsy Service Revenue Market Share, 2018-2029
Figure 9. By Application - Global Cancer Cell Biopsy Service Revenue Market Share, 2018-2029
Figure 10. By Type - Global Cancer Cell Biopsy Service Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Cancer Cell Biopsy Service Revenue Market Share, 2018-2029
Figure 12. By Application - Global Cancer Cell Biopsy Service Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Cancer Cell Biopsy Service Revenue Market Share, 2018-2029
Figure 14. By Region - Global Cancer Cell Biopsy Service Revenue Market Share, 2018-2029
Figure 15. By Country - North America Cancer Cell Biopsy Service Revenue Market Share, 2018-2029
Figure 16. US Cancer Cell Biopsy Service Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Cancer Cell Biopsy Service Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Cancer Cell Biopsy Service Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Cancer Cell Biopsy Service Revenue Market Share, 2018-2029
Figure 20. Germany Cancer Cell Biopsy Service Revenue, (US$, Mn), 2018-2029
Figure 21. France Cancer Cell Biopsy Service Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Cancer Cell Biopsy Service Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Cancer Cell Biopsy Service Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Cancer Cell Biopsy Service Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Cancer Cell Biopsy Service Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Cancer Cell Biopsy Service Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Cancer Cell Biopsy Service Revenue Market Share, 2018-2029
Figure 28. China Cancer Cell Biopsy Service Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Cancer Cell Biopsy Service Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Cancer Cell Biopsy Service Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Cancer Cell Biopsy Service Revenue, (US$, Mn), 2018-2029
Figure 32. India Cancer Cell Biopsy Service Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Cancer Cell Biopsy Service Revenue Market Share, 2018-2029
Figure 34. Brazil Cancer Cell Biopsy Service Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Cancer Cell Biopsy Service Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Cancer Cell Biopsy Service Revenue Market Share, 2018-2029
Figure 37. Turkey Cancer Cell Biopsy Service Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Cancer Cell Biopsy Service Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Cancer Cell Biopsy Service Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Cancer Cell Biopsy Service Revenue, (US$, Mn), 2018-2029
Figure 41. ANGLE Cancer Cell Biopsy Service Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Fluxion Biosciences Cancer Cell Biopsy Service Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Inivata Cancer Cell Biopsy Service Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. GRAIL Cancer Cell Biopsy Service Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Guardant Health Cancer Cell Biopsy Service Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Caris Cancer Cell Biopsy Service Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Liquid Biopsy Labs Cancer Cell Biopsy Service Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. DermTech Cancer Cell Biopsy Service Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. QIAGEN Cancer Cell Biopsy Service Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Lucence Cancer Cell Biopsy Service Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Biocept Cancer Cell Biopsy Service Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. CELLSEARCH Cancer Cell Biopsy Service Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
